Skip to main content

Table 2 Five-year incidence of dyslipidaemia (Page 7)

From: Risk prediction model of dyslipidaemia over a 5-year period based on the Taiwan MJ health check-up longitudinal database

 

Number(all)

Percentage within all (%)

Percentage within dyslipidaemia (%)

Percentage within item (%)

Developed into dyslipidaemia

1170

19.39

  

 1 item

819

13.58

70.00

 

  HDL-C

515

8.54

44.02

62.88

  TC

135

2.24

11.54

16.48

  TG

123

2.04

10.51

15.02

  LDL-C

46

0.76

3.93

5.62

 2 item

290

4.81

24.79

 

  LDL-C & TC

167

2.77

14.27

57.59

  HDL-C & TG

80

1.33

6.84

27.59

  TG & TC

24

0.40

2.05

8.28

  LDL-C & HDL-C

18

0.30

1.54

6.21

  HDL-C & TC

1

0.02

0.09

0.34

  LDL-C & TG

0

0.00

0.00

0.00

 3 item

23

0.38

1.97

 

  LDL-C & TG &TC

10

0.17

0.85

43.48

  LDL-C & HDL-C & TC

9

0.15

0.77

39.13

  TC & HDL-C & TG

4

0.07

0.34

17.39

  LDL-C & HDL-C & TG

0

0.00

0.00

0.00

 4 item

2

0.03

0.17

 

  TC & LDL-C & HDL-C& TG

2

0.03

0.17

 

Lipid-lowering medication

36

0.60

3.08

 

Remaining normal

4863

80.61

  
  1. Note: The incidence of dyslipidaemia in the table is the crude incidence e and does not standardize by age and sex